Dr. Patrick F. Timmins III, MD

Dr. Timmins practices at Jack D Weiler Hospital in Bronx, New York.

Dr. Timmins' NPI, 1942297080, was assigned on October 4, 2005. Dr. Timmins graduated from Ohio State College of Medicine in 1992. Dr. Timmins holds New York license 202700.

Dr. Timmins' primary practice is Jack D Weiler Hospital, at 1825 Eastchester Rd, Bronx, NY 10461 in Bronx County. The practice phone is (914) 377-4722.

Dr. Timmins' primary practice is Jack D Weiler Hospital in Bronx, New York. Dr. Timmins is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Timmins to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Timmins practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Timmins' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Timmins is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Timmins' licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Timmins treats.

CMS data shows 6,864 Medicare services from Dr. Timmins across 21 procedure codes in 2024, for 273 Medicare patients. Medicare paid $120,507 for them.

CMS counts 273 Medicare patients who saw Dr. Timmins in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Timmins' median patient age at 70, with 98% women.

In 2024, Dr. Timmins wrote 336 Medicare Part D claims for 151 patients. 88% of them were for generic drugs. CMS names the drug for 168 of them, across 7 drugs with 11 or more claims each, at $11,083 in total drug cost. In 2023, CMS named 255 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Timmins for performance year 2024, reported as part of a group. CMS lists Dr. Timmins as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Timmins, published from 2005 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Endometrial Neoplasms, Genital Neoplasms, Female and Gynecologic Surgical Procedures. Dr. Timmins has published most often in Gynecol Oncol. Dr. Timmins' most frequent co-authors are Ronald D. Alvarez, MD, Laura Jean Havrilesky, MD and Elizabeth Lin Jewell, MD.

Dmand AI links Dr. Timmins to 1 clinical trial.

CMS Open Payments shows 50 general payments to Dr. Timmins from 17 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 94% of the total. Clovis Oncology, Inc. paid the most, $349.

Dmand AI lists 2 awards for Dr. Timmins.

Dr. Timmins graduated from Ohio State College of Medicine in 1992. Dr. Timmins is a member of ACS, ENDO and SLS.

Dr. Timmins is in network with 10 carriers, including Aetna, MVP Health Care and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.